JP2020523370A5 - - Google Patents

Download PDF

Info

Publication number
JP2020523370A5
JP2020523370A5 JP2019569215A JP2019569215A JP2020523370A5 JP 2020523370 A5 JP2020523370 A5 JP 2020523370A5 JP 2019569215 A JP2019569215 A JP 2019569215A JP 2019569215 A JP2019569215 A JP 2019569215A JP 2020523370 A5 JP2020523370 A5 JP 2020523370A5
Authority
JP
Japan
Prior art keywords
cancer
nutritional supplement
selenium
fish oil
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019569215A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020523370A (ja
JP7788129B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/037274 external-priority patent/WO2018231943A2/en
Publication of JP2020523370A publication Critical patent/JP2020523370A/ja
Publication of JP2020523370A5 publication Critical patent/JP2020523370A5/ja
Priority to JP2023108547A priority Critical patent/JP2023115357A/ja
Priority to JP2025235858A priority patent/JP2026026381A/ja
Application granted granted Critical
Publication of JP7788129B2 publication Critical patent/JP7788129B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019569215A 2017-06-13 2018-06-13 癌化学療法を増強するための組成物および方法 Active JP7788129B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023108547A JP2023115357A (ja) 2017-06-13 2023-06-30 癌化学療法を増強するための組成物および方法
JP2025235858A JP2026026381A (ja) 2017-06-13 2025-12-05 癌化学療法を増強するための組成物および方法

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201762519096P 2017-06-13 2017-06-13
US201762519093P 2017-06-13 2017-06-13
US62/519,096 2017-06-13
US62/519,093 2017-06-13
US201762595002P 2017-12-05 2017-12-05
US62/595,002 2017-12-05
US201862670275P 2018-05-11 2018-05-11
US62/670,275 2018-05-11
PCT/US2018/037274 WO2018231943A2 (en) 2017-06-13 2018-06-13 Compositions and methods for enhancing cancer chemotherapy

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023108547A Division JP2023115357A (ja) 2017-06-13 2023-06-30 癌化学療法を増強するための組成物および方法

Publications (3)

Publication Number Publication Date
JP2020523370A JP2020523370A (ja) 2020-08-06
JP2020523370A5 true JP2020523370A5 (enExample) 2021-07-26
JP7788129B2 JP7788129B2 (ja) 2025-12-18

Family

ID=64658652

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019569215A Active JP7788129B2 (ja) 2017-06-13 2018-06-13 癌化学療法を増強するための組成物および方法
JP2023108547A Pending JP2023115357A (ja) 2017-06-13 2023-06-30 癌化学療法を増強するための組成物および方法
JP2025235858A Pending JP2026026381A (ja) 2017-06-13 2025-12-05 癌化学療法を増強するための組成物および方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023108547A Pending JP2023115357A (ja) 2017-06-13 2023-06-30 癌化学療法を増強するための組成物および方法
JP2025235858A Pending JP2026026381A (ja) 2017-06-13 2025-12-05 癌化学療法を増強するための組成物および方法

Country Status (9)

Country Link
US (2) US10905725B2 (enExample)
EP (1) EP3638247A4 (enExample)
JP (3) JP7788129B2 (enExample)
KR (2) KR20240171182A (enExample)
CN (1) CN111556754A (enExample)
CA (1) CA3066713A1 (enExample)
IL (1) IL271328A (enExample)
TW (2) TW202535473A (enExample)
WO (1) WO2018231943A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3038327C (en) * 2016-10-03 2024-03-12 Houn Simon Hsia Compositions and methods for enhancing cancer radiotherapy
US12029765B2 (en) * 2017-06-13 2024-07-09 Houn Simon Hsia Compositions and methods for treating cancer
JP7788129B2 (ja) 2017-06-13 2025-12-18 シャー，ホウン・サイモン 癌化学療法を増強するための組成物および方法
CA3066742A1 (en) 2017-06-13 2018-12-20 Houn Simon Hsia Compositions and methods for enhancing hyperthermia therapy
TWI805589B (zh) 2017-06-13 2023-06-21 夏滉 增進癌症放射線療效之營養補充劑的用途
CN114072155A (zh) * 2019-04-01 2022-02-18 豪恩·西蒙·夏 用于癌症免疫疗法的组合物和方法
AU2021324673B2 (en) * 2020-08-10 2025-07-24 Houn Simon Hsia Compositions and methods for treating viral infection

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4348483A (en) 1981-01-23 1982-09-07 Universal Foods Corporation Method for the production of chromium yeast
US4569836A (en) 1981-08-27 1986-02-11 Gordon Robert T Cancer treatment by intracellular hyperthermia
CA2010511A1 (en) 1989-03-01 1990-09-01 Roberto L. Ceriani Method of enhancing cancer therapy by administration of unsaturated fatty acids
NZ248605A (en) 1993-05-28 1994-12-22 Abbott Lab Enteral nutritional product comprising protein and fat
US20020010144A1 (en) 1994-04-29 2002-01-24 Robert Sobol Enhancing the sensitivity of tumor cells to therapies
US5976548A (en) 1994-11-08 1999-11-02 Viva America Marketing, Inc. Nutritional supplement composition and use
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
US6440464B1 (en) 1996-06-10 2002-08-27 Viva Life Science Nutritive composition for cardiovascular health containing fish oil, garlic, rutin, capsaicin, selenium, vitamins and juice concentrates
US6197295B1 (en) * 1996-09-25 2001-03-06 Viva America Marketing Corporation Dietary supplementation with, and methods for administration of yeast-derived selenium product
US5810888A (en) 1997-06-26 1998-09-22 Massachusetts Institute Of Technology Thermodynamic adaptive phased array system for activating thermosensitive liposomes in targeted drug delivery
EP1100517A1 (en) 1998-08-04 2001-05-23 John V. Kosbab Nutrient and therapeutic compositions for the treatment of cancer
US7569551B2 (en) 2000-02-25 2009-08-04 The University Of British Columbia Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides
EP1383573A4 (en) 2001-03-26 2005-09-14 Ellen A Inc METHOD AND DEVICE FOR THE TREATMENT OF ANGRYED TISSUE
WO2003035108A1 (en) 2001-10-25 2003-05-01 Ttc Co., Ltd. Immunopotentiators in thermotherapy for cancer
MXPA04006717A (es) 2002-01-11 2004-11-10 Matthias Rath Una formulacion farmaceutica nutriente que comprende polifenoles y su uso para el tratamiento del cancer.
US20040087490A1 (en) 2002-09-20 2004-05-06 Troup John P. Nutritional compositions
AU2002951833A0 (en) 2002-10-02 2002-10-24 Novogen Research Pty Ltd Compositions and therapeutic methods invloving platinum complexes
US7744930B2 (en) 2002-11-22 2010-06-29 Shaklee Corporation Compositions, methods and kits for enhancing weight loss while inhibiting loss of lean body mass
US8663679B2 (en) 2004-04-29 2014-03-04 Abbott Laboratories Compositions for improving breast health in women
US9107864B2 (en) 2004-06-07 2015-08-18 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
US20060088574A1 (en) 2004-10-25 2006-04-27 Manning Paul B Nutritional supplements
US20070116802A1 (en) 2005-11-23 2007-05-24 Carl Germano High quality caloric composition
US8017147B2 (en) 2008-04-07 2011-09-13 Mazed Mohammad A Nutritional supplement for the prevention of cardiovascular disease, alzheimer's disease, diabetes, and regulation and reduction of blood sugar and insulin resistance
US20090110674A1 (en) 2007-10-24 2009-04-30 Loizou Nicos C Health supplement
WO2009157759A1 (en) 2008-06-23 2009-12-30 N.V. Nutricia Nutritional composition for improving the mammalian immune system
CN102164595A (zh) 2008-09-19 2011-08-24 雀巢产品技术援助有限公司 抗癌治疗中的免疫系统营养支持
US8257694B2 (en) 2009-05-14 2012-09-04 Product Partners, Llc Nutritional compositions for reducing oxidative damage
WO2010138902A1 (en) 2009-05-29 2010-12-02 New Chapter Inc. Compositions and methods for modulating lipid composition
KR101275724B1 (ko) 2009-12-09 2013-06-17 한국전자통신연구원 단일 기판 집적 회로 장치 및 그 제조 방법
WO2011094579A2 (en) 2010-01-29 2011-08-04 New Chapter Inc. Mushroom compositions and methods for making and using
WO2011115062A1 (ja) * 2010-03-15 2011-09-22 国立大学法人 岡山大学 抗腫瘍作用補助剤
US20120010688A1 (en) 2010-07-09 2012-01-12 Lamb Karl J Implantable conductive element and method of use inhyperthermic treatment
EP2598139A4 (en) 2010-07-26 2013-12-25 Chemotherapeutics Llc COMPOSITIONS AND METHODS FOR INCREASING THE EFFECTIVENESS OF SYSTEMIC, HIPEC, IP AND ASSOCIATED CANCER TREATMENTS
WO2012122295A2 (en) * 2011-03-07 2012-09-13 Ned Biosystems, Inc. Treatment for pancreatic adenocarcinoma and other cancers of epithelial origin
WO2014054884A1 (ko) 2012-10-05 2014-04-10 연세대학교 산학협력단 민감화 물질을 포함하는 온열 치료용 조성물
US9072768B2 (en) 2013-01-22 2015-07-07 Kibow Biotech, Inc. Composition and method for increasing effectiveness of radiation or chemotherapy
US9107947B2 (en) 2013-01-31 2015-08-18 The Penn State Research Foundation Anti-cancer compositions and methods
US9889092B2 (en) 2013-03-13 2018-02-13 The Board Of Regents Of The University Of Texas System Low density lipoprotein nanocarriers for targeted delivery of omega-3 polyunsaturated fatty acids to cancer
US20140294795A1 (en) 2013-03-28 2014-10-02 Houn Simon Hsia Nutritional Composition
WO2014175748A1 (en) 2013-04-22 2014-10-30 Smartfish As Use of a composition comprising fish oil and juice for the treatment and/or post treatment of cancer
SG11201600657RA (en) 2013-07-31 2016-02-26 Meiji Co Ltd Nutritional composition for inhibiting growth of tumor
EP3033091B1 (en) 2013-08-16 2022-09-07 Versitech Limited Probiotic composition and use thereof in the prevention and treatment of hepatocellular carcinoma
US20170246136A1 (en) 2014-09-24 2017-08-31 OliVentures, Inc. Pharmaceutical product, medical food or dietary supplement for preventing cancer and inflammatory diseases
CN105641000A (zh) 2015-06-01 2016-06-08 深圳市康道生物有限公司 一种含灰树花提取物的抗肿瘤组合物及其制备方法
KR20180081602A (ko) 2015-11-18 2018-07-16 사이버그 컨설팅, 엘엘씨 천연 추출물을 함유하는 조성물 및 피부 및 모발을 위한 그의 용도
CN105617358A (zh) * 2015-12-29 2016-06-01 广州市戴菊科技发展有限公司 一种具有抗肿瘤功能的医用食品及其制备方法
JP6376186B2 (ja) 2016-08-04 2018-08-22 トヨタ自動車株式会社 サスペンションメンバ
CA3038327C (en) 2016-10-03 2024-03-12 Houn Simon Hsia Compositions and methods for enhancing cancer radiotherapy
CN106822560A (zh) 2017-04-07 2017-06-13 湖北工程学院 药物组合物及其制备方法
JP7788129B2 (ja) * 2017-06-13 2025-12-18 シャー，ホウン・サイモン 癌化学療法を増強するための組成物および方法
TWI805589B (zh) 2017-06-13 2023-06-21 夏滉 增進癌症放射線療效之營養補充劑的用途

Similar Documents

Publication Publication Date Title
Heffeter et al. The ruthenium compound KP1339 potentiates the anticancer activity of sorafenib in vitro and in vivo
Fazio et al. Chemotherapy in gastroenteropancreatic (GEP) neuroendocrine carcinomas (NEC): a critical view
Ghoneum et al. Modified arabinoxylan from rice bran, MGN-3/biobran, sensitizes metastatic breast cancer cells to paclitaxel in vitro
Momeni et al. Effect of silymarin in the prevention of cisplatin nephrotoxicity, a clinical trial study
Calvaruso et al. Cannabinoid-associated cell death mechanisms in tumor models
Athira et al. Flavonoids, the emerging dietary supplement against cisplatin-induced nephrotoxicity
Ikehata et al. Different effects of epigenetic modifiers on the cytotoxicity induced by 5-fluorouracil, irinotecan or oxaliplatin in colon cancer cells
WO2012122295A2 (en) Treatment for pancreatic adenocarcinoma and other cancers of epithelial origin
Sreenivasan et al. Synergistic effect of curcumin in combination with anticancer agents in human retinoblastoma cancer cell lines
Jafarzadeh et al. Combined regimens of cisplatin and metformin in cancer therapy: A systematic review and meta-analysis
Fakih et al. Selenium protects against toxicity induced by anticancer drugs and augments antitumor activity: a highly selective, new, and novel approach for the treatment of solid tumors
JP2011515481A5 (enExample)
WO2018083713A1 (en) Composition comprising combination of epicatechin and anti-cancer compound
JP2020523374A5 (enExample)
Johnson et al. Luteolin and gemcitabine protect against pancreatic cancer in an orthotopic mouse model
Sun et al. Comparison of hypoxia-activated prodrug evofosfamide (TH-302) and ifosfamide in preclinical non-small cell lung cancer models
WO2018231943A3 (en) COMPOSITIONS AND METHODS FOR IMPROVING CHEMOTHERAPY TREATMENT OF CANCER
Raina et al. Molecular insight into apoptosis mediated by flavones in cancer
JP2020523375A5 (enExample)
Chhabra et al. Silibinin: A promising anti-neoplastic agent for the future? A critical reappraisal
Correale et al. A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinoma
Matsuo Natural products and cancer
Kawasaki et al. Therapeutic potential of garlic, aged garlic extract and garlic‑derived compounds on pancreatic cancer
Taghvaei et al. Carboplatin and epigallocatechin-3-gallate synergistically induce cytotoxic effects in esophageal cancer cells
Mihlon et al. Chemotherapy agents: a primer for the interventional radiologist